An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

Clinical Trial ID: NCT03964168

Description

Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.

Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.


Criteria

Inclusion Criteria: - Male or female adults ≥ 18 years of age. - Was receiving first or second biologic therapy - Has not had a follow up with treating physician in ≥ 9 months Exclusion Criteria: - Actively receiving biologic therapy - Was not receiving first or second biologic therapy

  • Start Date

    2019-05-14

  • Last Updated

    2019-05-24

  • Sponsor

    Janssen Scientific Affairs, LLC

  • Condition Name

    Psoriasis

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.